Ticagrelor


( Last Updated : June 1, 2011)
Generic Name:
Ticagrelor
Project Status:
Complete
Therapeutic Area:
Acute coronary syndromes
Manufacturer:
AstraZeneca Canada Inc
Call for patient/clinician input open:
Brand Name:
Brilinta
Project Line:
Reimbursement Review
Project Number:
SR0234-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Thrombotic events in Acute Coronary Syndromes, Prevention
Recommendation Type:
Do not list
Final Recommendation: